Intravitreal versus posterior subtenon injection of triamcinolone acetonide for treatment of diabetic macular edema / Samira Abdeljalil Elfassi ; Supervised Hany Salah Eldin Hamza , Ramy Riad Fekry , Dina Hossam Eldin Hassanin
Material type:
TextLanguage: English Publication details: Cairo : Samira Abdeljalil Elfassi , 2015Description: 101 P. : charts , facsimiles ; 25cmOther title: - المقارنة بين حقن الجسم الزجاجي وحقن غمد المقلة (خلف لفافة تينون) بمادة الترايامسينولون لعلاج الارتشاح السكري لمركز الابصار [Added title page title]
- Issued also as CD
| Item type | Current library | Home library | Call number | Copy number | Status | Barcode | |
|---|---|---|---|---|---|---|---|
Thesis
|
قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.24.M.Sc.2015.Sa.I (Browse shelf(Opens below)) | Not for loan | 01010110069686000 | ||
CD - Rom
|
مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.11.24.M.Sc.2015.Sa.I (Browse shelf(Opens below)) | 69686.CD | Not for loan | 01020110069686000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Ophthalmology
Currently there are many treatment modalities and strategies for DME. Many recent clinical studies show that intravitreal injection of the corticosteroid Triamcinolone Acetonide (TAA) reduce edematous retinal swelling and improve visual acuity in patients with DME. The objective of our prospective comparative study, which included 30 eyes randomized into two groups, was to assess the efficacy and safety of the posterior subtenon injection of Triamcinolone Acetonide as compared to intravitreal injection for the treatment of diabetic macular edema. The results showed similar improvements in visual acuity and significant decrease in central macular thickness (CMT) in both groups throughout the 3 months follow up period. However the IOP in the intravitreal injection group was significantly higher than in the posterior subtenon injection group at 1 and 3 months after injection
Issued also as CD
There are no comments on this title.